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Abstract
Trypanosoma cruzi, the flagellate protozoan agent of Chagas disease or American trypano-
somiasis, is unable to synthesize sialic acids de novo. Mucins and trans-sialidase (TS) are
substrate and enzyme, respectively, of the glycobiological system that scavenges sialic
acid from the host in a crucial interplay for T. cruzi life cycle. The acquisition of the sialyl resi-
due allows the parasite to avoid lysis by serum factors and to interact with the host cell. A
major drawback to studying the sialylation kinetics and turnover of the trypomastigote glyco-
conjugates is the difficulty to identify and follow the recently acquired sialyl residues. To
tackle this issue, we followed an unnatural sugar approach as bioorthogonal chemical
reporters, where the use of azidosialyl residues allowed identifying the acquired sugar.
Advanced microscopy techniques, together with biochemical methods, were used to study
the trypomastigote membrane from its glycobiological perspective. Main sialyl acceptors
were identified as mucins by biochemical procedures and protein markers. Together with
determining their shedding and turnover rates, we also report that several membrane pro-
teins, including TS and its substrates, both glycosylphosphatidylinositol-anchored proteins,
are separately distributed on parasite surface and contained in different and highly stable
membrane microdomains. Notably, labeling for α(1,3)Galactosyl residues only partially
colocalize with sialylated mucins, indicating that two species of glycosylated mucins do
exist, which are segregated at the parasite surface. Moreover, sialylated mucins were
included in lipid-raft-domains, whereas TS molecules are not. The location of the surface-
anchored TS resulted too far off as to be capable to sialylate mucins, a role played by the
shed TS instead. Phosphatidylinositol-phospholipase-C activity is actually not present in try-
pomastigotes. Therefore, shedding of TS occurs via microvesicles instead of as a fully solu-
ble form.
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Author Summary
Trypanosoma cruzi is a flagellated protozoan parasite whose life cycle includes stages alter-
nating between insect and mammal hosts. The membrane of the infective trypomastigote
is equipped to allow survival in blood and to invade cells where it proliferates. Here we
provide a novel description of the localization in separate microdomains of the trans-siali-
dase and mucins, enzyme and substrate, respectively, that play the main role in the crucial
scavenging of sialic acids from the host, which allows parasite survival and infection. Even
though these proteins, key in the parasite biology, share similar anchoring to the mem-
brane, their puzzling segregation evidences the complexity of the trypanosome virulence
mechanisms and protein trafficking. Instead of as soluble proteins, they are shed in micro-
vesicles, a finding relevant to their known role in the pathogenesis of T. cruzi infection.
This work provides an integrated view that explores these phenomena at the nanoscale
and allows to build a model for the trypomastigote membrane physiology.
Introduction
Trypanosoma cruzi, the agent of Chagas disease or American trypanosomiasis, is unable to syn-
thesize sialic acids, entirely depending on a modified α(2,3)-sialidase known as trans-sialidase
(TS) to scavenge them from the host’s glycoconjugates through a glycosyl-transfer reaction. TS
constitute a family of glycosylphosphatidylinositol (GPI)-anchored proteins consisting of a cat-
alytic domain followed by an extension of a repetitive motif composed by twelve aminoacid
residues known as SAPA. TS awakens great interest and has been extensively studied based on
its biochemical properties, relevance in parasite cell biology and in the induction of strong
alterations on the host immune response [1–3]. GPI-anchored-TS is expressed in the infective
parasite (trypomastigote) stage and can be easily found in sera from acutely infected mammals
or in trypomastigote-conditioned medium after shedding [4, 5]. Hence, TS is considered a vir-
ulence factor of T. cruzi.
In the presence of suitable donors (i.e. glycans with an α(2–3)-sialyl residue linked to a ter-
minal β-Galactose), the parasite’s surface becomes rapidly sialylated by TS [6]. Sialyl acceptor
molecules and TS constitute a glycobiological system crucial in the T. cruzi life cycle [7]. Sialy-
lation of the parasite surface by TS is a requisite to avoid lysis by serum factors [8, 9] and thus
sialylation occurs as acceptor glycoconjugates become exposed on the surface. Parasite glyco-
conjugates conform a dense negatively charged coat [8], which is also associated to the invasion
of the host cell [7]. Although probably not the unique acceptors available for the TS-transferred
sialyl residue, mucins are considered as its main targets [8, 10]. T. cruzimucins are a heteroge-
neous family of heavily O-glycosylated molecules (for a review see [11, 12]) that are also shed
to the milieu and have strong pro-inflammatory properties on the host [13–15]. Previous
genetic, biochemical and proteomic studies revealed that the highly polymorphic TcMUC gene
family, and particularly those genes belonging to the TcMUC II subgroup, code for the peptide
scaffolds of 60–200 kDa mucins restricted to the trypomastigote surface and known as tGPI-
mucins [16, 17]. Despite their complexity and variations in amino acid sequence, TcMUC II
deduced products share a common structure made up of a highly conserved N-terminal signal
peptide, a variable and central region showing highly biased amino acid composition, in which
Thr, Ser, Pro, Gly, and Ala residues together might add up to 60–80% of the total count, and a
C-terminal GPI attachment signal. Besides the TcMUC genes, other families of glycosylated
proteins families such as TcTASV [18] and MASP [7] are being discovered. To date, the struc-
ture of the O-linked oligosaccharides has only been determined for the mucins from the non-
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infective insect epimastigote stage (known as Gp35/50 mucins) of different strains of T. cruzi
[12]. Little is known about the structure of the O-glycans of the trypomastigotes mucins. The
larger structures are branched, contain a variable number of Galp units and can be sialylated
indicating the presence of ßGal terminal residues [19, 20]. The simplest structures found corre-
spond to Galα(1,3)Galβ(1,4)GlcNAcα epitopes (known as αGal), which are only found in try-
pomastigote mucins and constitute a main target of protective and lytic antibody responses in
Chagasic patients [20, 21].
Due to its biologic relevance in the host/parasite interaction, it is of high interest to fully
understand the sialic acid acquisition process together with the distribution of the acceptor
molecules on the T. cruzi surface. A major drawback to analyze the kinetics of the infective try-
pomastigote acceptors is the difficulty to identify and follow the recently acquired sialyl resi-
dues. To tackle this issue, we followed an unnatural sugar approach as bioorthogonal chemical
reporters [22, 23]. The use of modified azidosialyl residues allowed us to identify the TS-cata-
lyzed modification of the glycosylation pattern of parasites and cells from the immune system
[6] with unnoticeable chemical perturbation. In this way, TS target proteins can be studied to
the molecular level with higher selectivity and minimal background in contrast to the use of
mucin-directed antibodies or lectins.
In T. cruzi, it has been proposed that proteins are located in different regions of the parasite
surface following a spatial distribution that may be associated with their functions [24].
Recently, we reported that GPI-anchored proteins reach the parasite surface by an unconven-
tional pathway that involves the contractile vacuole [25]. However, even when TS and mucin-
like TSSA [26] are GPI-anchored proteins they are trafficked via different routes thus suggest-
ing a strategy to differentially locate them into defined/specific regions of the membrane [25].
To clarify the T. cruzi trypomastigote membrane biology and structure as well as protein
turnover we addressed the TS and sialyl acceptors surface distribution, turnover kinetics, sialy-
lation and shedding processes. Here we report for the first time that several membrane proteins
including TS and its targets are separately distributed on T. cruzi surface and contained in dif-
ferent and highly stable membrane microdomains. This location resulted too far off for the sur-
face-anchored TS to sialylate mucins, a role played by the shed TS instead. In addition, we
report that TS is shed only associated to microvesicles and not in a fully soluble form, thus
challenging the general assumption that, in trypomastigotes, GPI-anchored proteins are shed
after phosphatidylinositol-phospholipase-C (PI-PLC) hydrolysis. We also provide new evi-
dence that mucins are actually the main sialyl acceptor molecules and that at least two glycosy-
lated species of mucins exists based on the presence of sialyl and α(1,3)Galactosyl (αGal)
residues.
Results
Characterization, shedding and turnover of trypomastigote’s sialyl
acceptors
The TS from living trypomastigotes accepts and readily sialylates the parasite surface with an
azido-modified sialyl residue (Neu5Az) [6] from a donor that is α(2–3)-linked to a β-galactose
such as (α2–3)azidosialyl-lactose (Neu5AzLac) or (α2–3)azidosialyl-β-galactose (Neu5AzGal)
(Fig 1). The azido group is then covalently coupled to a phosphine-FLAG compound through a
Cu2+-free click chemistry [22, 23], allowing to tag the transferred sialyl residue that, in turn, can
be easily identified by anti-FLAG antibodies (Fig 1A). This unnatural sugar strategy allows analyze
the labeling kinetics and fate of the sialyl residue on the parasite surface at the molecular level.
Following this approach, we supplied these sugar donors to live trypomastigotes to allow
them to acquire the Neu5Az residue into their surface (Fig 1B) by means of the parasite TS.
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The Neu5Az residue was incorporated to diffuse bands between 60 and 190 kDa corresponding
to the relative molecular mass for mucins of the trypomastigote stage [20]. To determine the
mucin nature of the labeled material, we purified trypomastigote’s mucins following a standard
butan-1-ol extraction protocol [8, 20]. Results shown in Fig 1C indicate that the sialylated
material was isolated mainly in the F2 and F3 fractions, which are highly enriched in mucin-
Fig 1. Mucin sialylation and characterization. A) Mucins (or any glycoconjugate bearing a terminal β-galactose) may be tagged by the TS using a Neu5Az
donor such as Neu5Azα(2–3)LacβOMe. Then the Azide group may be coupled via the Staudinger-Bertozzi chemistry or the Cu2+-free click chemistry to
obtain a FLAG or biotin tag ready for detection. B) Western blot of Neu5Az trans-sialylated trypomastigote lysates revealing the relative molecular mass
distribution of acceptor molecules. A line profile of the blot is also plotted. Neg Ctrl: Negative control. C) Neu5Az trans-sialylated parasites were submitted to
organic solvents extraction as described in [20] to determine their mucin nature. Extracted material was subjected to Western blot. F1, F2 and F3 refer to the
different purification fractions (for details see M&M). D) Neu5Az trans-sialylated trypomastigotes (900x106) were lysed and sialylated proteins pulled-down
with anti-FLAG antibodies. Western blots of this material were revealed with anti-TcMUC II antibodies. E-F) Confocal images displaying partial colocalization
of anti-FLAG and anti-TcMUC II (E) or anti-αGal (F) labeling at the parasite surface.
doi:10.1371/journal.ppat.1005559.g001
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type glycoconjugates [8, 20]. The residual signal in F1, whose relative molecular masses coin-
cide with that present in F2/F3, is consequence of a single extraction round. In agreement with
that reported by Almeida et al [20], sialylated material and αGal containing mucins have iden-
tical purification patterns.
To further determine the sialylation of mucins, antibodies anti-FLAG were used to pull-
down the Neu5Az-labeled material and retained and unbound fractions tested in Western
blots using an antibody against the central and variable region of a defined TcMUC II product,
a known trypomastigote mucin family [17]. As shown in Fig 1D, anti-TcMUC II reactivity was
restricted to the bound, and thus Neu5Az-labeled fraction. In the same line, immunofluores-
cence experiments showed partial colocalization of TcMUC II and Neu5Az-labeling at the try-
pomastigote surface (Fig 1E). The relatively weak signal provided by the anti-TcMUC II
antibody as compared to those yielded by anti-FLAG or anti-αGal (which recognizes the
broadly distributed and immunodominant glycotope αGal) is consistent with the simultaneous
expression of multiple TcMUC II products on the trypomastigote surface [17]. Despite this
fact, results point to tGPI-mucins as main targets of the TS activity under our experimental
conditions.
In search for another known surface marker of glycoproteins, we tested the αGal residue
distribution. This residue is associated with mucin glycosylation although it is also present in
other sialylated proteins such as Tc85 [27]. Given that sialylated and αGalactosylated proteins
copurify in a mucin purification procedure, we were interested into analyze their display on the
surface of the trypomastigote. Both Neu5Az and αGal displayed a dotted pattern but only par-
tially colocalized. Given that Neu5Az and αGal are both linked to ßGal residues, this observa-
tion arises interesting questions regarding intracellular vs. extracellular mucin modifications.
This finding also supports the presence of two types of mucins characterized by their glycosyla-
tion pattern and surface location.
To analyze the shedding kinetics of Neu5Az-containing acceptors, live trypomastigotes
were pulsed with Neu5AzLac and the shedding kinetics of sialylated mucins was followed by
immunofluorescence, which was determined by flow cytometry in aliquots withdrawn every 30
minutes. Most of the acquired labeled sialic acid was lost after 120 minutes but, interestingly,
parasites re-incubated with Neu5AzLac re-acquired sialic acid labeling to the saturating level
(Fig 2A, Violet curve), indicating that sialyl acceptors had become available again. Relative
molecular masses of the acceptor proteins were determined by Western blots of parasite lysates
and conditioned media (Fig 2B). The sialyl residue was found associated to 80–150 kDa diffuse
bands identified as trypomastigote mucins [20]. As labeled mucin signal faded on the parasite
surface, it was increasingly recovered in the conditioned media indicating that the sialyl residue
was not hydrolyzed but conserved in the shed material. Thus, the acquisition of new labeling
indicates that de novo synthesized acceptor proteins have reached the parasite surface (and
became available to the TS activity). Immunofluorescence microscopy imaging of the shedding
process (Fig 2C) was in line with flow cytometry and Western blot findings. Sialic acid accep-
tors followed a dotted pattern distribution along the trypomastigote surface (see also below)
that fades in keeping with the shedding kinetics. Parasites allowed to re-sialylate after shedding
recovered their original labeling pattern. We found no special region or compartment of the
cell surface primarily associated with the shedding process or morphological differences
throughout the aliquots taken. TS staining was used as reference due to its continuous reposi-
tion to the trypomastigote surface [28]. Similar results indicating that no significant desialyla-
tion was involved were obtained in supporting assays where the only sialidase present, i.e. the
TS activity, was neutralized by the addition of mAb 13G9 [29] after the labeling period.
Therefore, mucins have a constant turnover on the parasite membrane being replaced by de
novo synthesized unsialylated proteins that acquire the sialyl residues as they become exposed
T. cruzi Surface Glycosylation
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on the surface to the sialyl donors and TS. Mucins half-life was estimated at 45 min with an
almost complete turnover in about 2 hours.
Sialylated mucins and TS are spatially segregated and show a spotted
pattern along the trypomastigote membrane
Live trypomastigotes were supplied with the Neu5AzLac donor and the acquired residue was
revealed with Dibenzocyclooctynes-FLAG (DBCO-FLAG), which increment labeling kinetic
rates by about 100-fold compared to phosphine reagents [30, 31]. Mucins were displayed in a
dotted pattern following an unforeseen distribution localized both in the cell body and flagel-
lum (Fig 1). As well as mucins, TS labeling followed a dotted pattern distributed along the fla-
gellum and the cell body [6, 29]. It can be expected that the enzyme would be located close
enough so as to allow the mucin sialylation to proceed. Notably, there was no colocalization
between TS and Neu5Az signals (Fig 3A). Taking into account that TS and mucins are not only
enzyme and substrate but also GPI-anchored proteins, their segregated distribution at the para-
site surface is certainly puzzling. To ensure that the pattern was not an artifact due to the fixa-
tion process, a panel of several fixatives and temperatures was assessed and no differences were
found.
Given the dimensions of the domains found for mucins and TS, we used a far-field superre-
solution fluorescence microscopy technique known as ground state depletion imaging
(GSDIM) [32], a suitable tool to analyze phenomena that occur at the nanometric scale. This
technique is based on the switching of most molecules from a conventional fluorophore to a
metastable dark state, followed by the stochastic spontaneous return of a few molecules to the
ground state where their position can be accurately estimated (Fig 3). The mucin domains were
found to be a heterogeneous population with a mean diameter of 90nm and a separation of
Fig 2. Shedding kinetics of sialylatedmucins. Living parasites were incubated with Neu5Az donor. A)
Acquired Neu5Az was followed by flow cytometry to determine its shedding kinetics. B) Western blot and C)
immunofluorescence of the parasites from (A). Western blots indicate that Neu5Az was readily accepted into
diffuse bands between 80-150kDa corresponding to the trypomastigote mucins [7]. The shed material was
recovered in the conditioned media indicating that the residue was not hydrolyzed but conserved in the shed
material. C) Fluorescence microscopy. Sialylated mucins fluorescence intensity fades while TS labeling
remains. Raw images are shown to avoid biased observations. Bar: 10μm.
doi:10.1371/journal.ppat.1005559.g002
T. cruzi Surface Glycosylation
PLOS Pathogens | DOI:10.1371/journal.ppat.1005559 April 8, 2016 6 / 29
Fig 3. Sialylated mucins and TS are included in segregated membranemicrodomains. A) Live trypomastigotes were sialylated and FLAG-tagged.
Sialylated mucins and TS rendered a dotted pattern on the trypomastigotes surface that did not co-localize (confocal microscopy). Line profiles for sialic acid
and TS signal in the flagellum (boxed area) showed that mucins and TS do not co-localize but were rather out-of-phase with each other. GSDIM
superresolution fluorescence microscopy performed for sialylated mucins (B) and TS (C) independently showed that mucins were included in domains 90 nm
wide and separated 120-500nm from each other. Results for TS were equivalent. Size and distribution of trypomastigote membrane domains explain why
under a confocal microscope, restricted to classical light diffraction limits, the domains for TS and mucins were not fully resolved.
doi:10.1371/journal.ppat.1005559.g003
T. cruzi Surface Glycosylation
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about 200-500nm between them. In addition, domains separated 60nm apart were found and
could be resolved (Fig 3B, box). Domains for TS were also a heterogeneous sized population and
similar mean diameters and distances between domains were recorded. Both for mucins and TS
the distances between domains were equivalent to those determined by confocal microscopy (see
Fig 3). However, GSDIM provided a 10-fold higher resolution that allowed determining accurate
domain sizes (3-fold smaller than calculated by confocal microscopy) and spaces between them,
enough for many others to be interspersed. These results provide further evidence that domains
for mucins and TS do not colocalize and thus shed TS is responsible for mucin sialylation.
Sialylated mucins are included in Lipid Rafts
The fact that sialyl-decorated mucins and TS were placed in discrete spots on the membrane of
trypomastigotes lead us towards their possible inclusion in specialized membrane domains.
Lipid rafts, or detergent resistant membranes (DRM) are a membrane organizing principle in
which sterols, sphingolipids and glycolipids coalesce together to form membrane nanodomains
with relative lower fluidity than the surrounding lipid bilayer [33]. Given their chemical com-
position, these domains tend to be enriched in GPI-anchored proteins and trans-membrane
proteins that are sorted into these thicker membrane domains to maximize hydrophobic inter-
actions [34]. Lipid rafts have already been described in several other protozoa [24] and in T.
cruzi epimastigotes [25], but not yet in trypomastigotes. To address whether TS and mucins
could localize to lipid rafts, cold Triton X-100 partition of Neu5Az-labeled trypomastigotes
was performed. Fig 4 shows that, while mucins were recovered in the pellet, TS was present in
the supernatant indicating mucin resistance to cold Triton X-100 extraction (Fig 4A). As a con-
trol, we also ran a Triton X-114 extraction. This detergent is miscible in aqueous solutions
under 23°C and separates in a dense phase above that temperature making it suitable to extract
GPI-anchored and lipophilic proteins. As expected, TS and mucins were recovered in the
detergent phase likely due to their GPI-anchored nature (Fig 4B). To purify DRMs, pulsed try-
pomastigotes were lysed with Triton X-100 either at 4°C or 37°C and centrifuged on a discon-
tinuous OptiPrep gradient. Neu5Az-labeled- mucins floated to the DRM fraction when lysis
was performed at 4°C but were found at the bottom of the gradient together with other cell
material when parasites were lysed at 37°C, temperature at which DRM are susceptible to
detergent disruption (Fig 4C). Interestingly, TS did not float to the interface under any condi-
tion, indicating its exclusion from DRMs. These data support that the chemical environment
in which mucins are located is different to that of TS, and provides independent evidence that
mucins and TS are segregated at the trypomastigote surface.
To further study the properties of lipid rafts of trypomastigotes we assayed the effect of
methyl-β-cyclodextrins [35], which severely altered the parasite structure (S1 Fig) and was
therefore discarded as a tool to analyze lipid rafts. To visually test for the presence of lipid rafts,
the trypomastigote membrane was fluidized with diethyl ether [35]. Neu5Az-sialylated para-
sites were exposed to diethyl ether for 30 or 90 seconds, immediately fixed and analyzed by
immunofluorescence. As shown in Fig 4D, membrane domains were still conserved when para-
sites were exposed to diethyl ether for 30sec. However, after a 90sec exposition, sialic acid label-
ing was no longer localized uniquely at discrete membrane domains being rather uniformly
distributed and even colocalizing with TS. This finding also indicates that the spotted pattern
was neither due to capping by intermolecular cross-linking by antibodies nor to the fixation
process, and supports that the fluidization of the parasites membrane disrupted the lipid rafts
containing the sialylated mucins as well as the TS domains. These findings suggest the previ-
ously unnoticed existence of membrane rafts in T. cruzi trypomastigotes and highlight the pos-
sible relevance that membrane compartmentalization might have in the parasite biology.
T. cruzi Surface Glycosylation
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Mucin distribution in epimastigote and metacyclic trypomastigote
surface
The distribution of mucins in the other parasite stages was analyzed following the same label-
ing strategy. Metacyclic trypomastigotes (the epimastigote-derived infectious form) were
assayed under the same conditions used for cell culture-derived parasites and displayed similar
distribution pattern (S2 Fig). Although epimastigotes (the replicative form found in the insect
vector) do not express TS, their mucins are efficiently sialylated by adding the soluble enzyme
Fig 4. Sialylated mucins are included in lipid rafts whereas TS is not. (A) Cold Triton X-100 partition.
Sialylated trypomastigotes were lysed at 4°C. Mucins were predominantly recovered in the pellet whereas TS
and HSP70, a cytosolic protein, were recovered in the supernatant. (B) Triton X-114 extraction for GPI-
anchored proteins. Parasites were lysed at 4°C and detergent and aqueous phases separated at 37°C and
analyzed byWestern blots. Mucins and TS partitioned in the detergent phase due to their GPI-anchoring.
Glutamate Dehydrogenase, a cytosolic protein, was recovered in the aqueous phase. (C) Purification of
DRMs by step-gradient ultracentrifugation. Trypomastigotes were lysed in Triton X-100 at 4°C or 37°C and
centrifuged in an Optiprep gradient. Mucins floated to the 35%-5% interface (lane 6) only when lysis was
done at 4°C indicating its DRM nature in contrast to TS. (D) Living parasites were sialylated from a Neu5Az
donor, then treated for membrane fluidization with 1% diethyl ether in phosphate-buffered saline (PBS) and
fixed with p-formaldehyde (PFA). Doted labeling for TS and mucins was disrupted only after 90sec treatment
even showing colocalization.
doi:10.1371/journal.ppat.1005559.g004
T. cruzi Surface Glycosylation
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in the presence of donors [36]. Although notoriously smaller in dot size [36], epimastigote
sialic acid staining displayed similar distribution all along the cell body and flagellum (S2A
Fig). Epimastigote mucins floated together with the lipid rafts when the Triton X-100 extrac-
tion was performed at 4°C but were found at the bottom when lysed at 37°C indicating that
they were also included in lipid rafts. Western blots analysis of the Optiprep gradients dis-
played diffuse bands between 35 and 60kDa, the expected mass of this stage-specific mucins
[10] (S2B Fig).
Amastigotes (the replicative intracellular stage in mammals) were collected from infected
cell-cultures and, due to the absence of TS expression in this stage, were tested for sialic acid
labeling by addition of recombinant TS and Neu5Az donors. However, no sialic acid labeling
at all was detected even though stage-specific mucins have been described [37]. The absence of
TS-available terminal ßGal residues in amastigote mucins (see Fig 5, panel Neu5Az/CCLP for
an unsialylated amastigote) agrees with the absence of TS-suitable sialylated donors in the cyto-
plasm of mammalian cells. The unnecessary expression of TS in this intracellular stage seems
to be an energy wasting process.
DRM-domains of T. cruzi are heterogeneous in size population and are
highly specific in their protein composition
To determine the protein composition of T. cruzi trypomastigote lipid rafts, mass spectrometry
(LC-MS-MS) was performed on trypsin-treated samples obtained after two-tandem raft purifi-
cation steps by discontinuous Optiprep gradient. Table 1 lists the most representative mem-
brane proteins identified (S1 Table lists all identified proteins).
The proteins listed in the table had already been demonstrated to be membrane proteins
and some were even found in the secretome of T. cruzi [46]. To validate the results obtained,
we selected several of these identified proteins and analyzed their surface distribution by fluo-
rescence microscopy. Recombinant Calpain-like cysteine peptidase (CLCP) [47], Kinetoplastid
membrane protein-11 (KMP-11) [41, 42] and Tol-T [40] were expressed in bacteria to elicit
antibodies in mice. Immunofluorescence assays (Fig 5) determined that these proteins were
also distributed in discrete membrane domains, indicating a correlation with lipid rafts purifi-
cation. Domains were smaller in size and mostly distributed in a linear pattern along the flagel-
lum. Furthermore, none of these proteins colocalized with sialylated mucins or TS. We then
tested Adenilate Kinase-1 (ADK-1) [39] that also exhibited a dotted pattern distributed both in
the cell body and flagellum (Fig 5). Once again, no colocalization was observed between ADK-
1 and mucins or TS. These results strongly support a segregation of different proteins along dif-
ferent membrane domains at the cell surface.
The puzzling non-colocalizing patterns found for the different proteins analyzed, together
with other reports of trypomastigote proteins that also displayed dotted patterns [18, 25, 48]
suggest a particular membrane topology with defined domains. To obtain highly solved topo-
logical information, we then assayed atomic force microscopy (AFM), a suitable tool that has
been used in epimastigotes [49, 50]. AFM imaging of trypomastigotes showed defined protru-
sions on their surface, consistent with the presence of microdomains (Fig 6). These knobs
could be visualized along the entire cell body and especially at the flagellum. These structures
were heterogeneous in shape and size, from 10nm to 90nm wide, and narrowly packed
together. Along the flagellum, they were displayed in parallel rows in an order that could sug-
gest their association with the cytoskeleton. Findings disclosed by AFM were also consistent
with those observed by GSDIM for both mucins and TS, thus providing topological evidence
supporting the distribution of these different molecules in intercalated and tightly packed
domains.
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TS and mucins are shed in microvesicles rather than via GPI-anchor
hydrolysis
It has been reported that enzymatically inactive components of the TS superfamily are found
in plasma membrane-derived microvesicles that are continuously shed by the parasite and that
modulate infection via poorly understood mechanisms [15, 46]. To analyze whether TS and
mucins are shed as soluble proteins or included in microvesicles, Neu5AzLac-pulsed trypomas-
tigotes were rinsed and incubated in serum-free RPMI with DBCO-Biotin. After 3 hours
microvesicles were purified with Exoquick from the conditioned medium and analyzed by
Western blot. Fig 7A shows that TS was shed exclusively in microvesicles and mucins were dis-
tributed mainly in the microvesicle fraction. Similar results were obtained when microvesicles
were collected from trypomastigote-conditioned media by ultracentrifugation (Fig 7B). In con-
trast, CLCP and TolT were not secreted by trypomastigotes (Fig 7A).
TS shedding in microvesicles rather than in a soluble form advocates against the hydrolysis
of the GPI-anchor by PI-PLC as has been proposed [28, 37, 51]. In support, it is noteworthy
that PI-PLC is not detected in trypomastigotes [52]. To analyze the relation between PI-PLC
and TS shedding we tested whether the hydrolysis of the GPI anchor shifts the TS distribution
from the microvesicle pellet to the supernatant. Digestion with recombinant PI-PLC was per-
formed before purifying the microvesicles (Fig 7C) or PI-PLC was added to trypomastigotes in
serum-free RPMI (Fig 7D). In both experimental set-ups, PI-PLC addition shifted TS localiza-
tion from the vesicles to the soluble fraction, thus strongly supporting that there is no parasite-
derived PI-PLC activity. Finally, to test whether differentiating amastigotes could be shedding
enough PI-PLC to digest the TS-GPI anchor, we tested for the presence of soluble TS in the
conditioned medium of an infected Vero cell culture (Fig 7E). Again, we only found TS associ-
ated to microvesicles rather than as a soluble protein. Thus, even if differentiating amastigotes
shed PI-PLC [53], the enzymatic activity is not enough to quantitatively hydrolyze the TS GPI-
anchor.
Fig 5. Distribution of proteins contained in DRMs. Proteins identified by mass spectrometry were
analyzed by immunofluorescence. KMP, TolT and CLCP were located in domains of the flagellum. ADK-1
displayed a dotted pattern in the cell body and in the flagellum. No co-localization with mucins or with TS was
found. Arrow points to an amastigote, this stage remains unsialylated. Bar: 5μm.
doi:10.1371/journal.ppat.1005559.g005
Table 1. Selected Hits fromMass Spectrometry Assays from Lipid Rafts Proteins.
Accession number Protein description References
407410164 small G-protein, putative Rab23 [38]
37727511 adenylate kinase 1 (ADK-1) [39]
71402301/ 71401264/ 71401268 surface protein Tol-T [40]
6166388 surface protein KMP11 [41, 42]
4234959 surface protein Tol-T3
71407177 inositol 1,4,5-trisphosphate receptor [43]
407845415/ 407391460 surface protein GP85 [44]
407831276/ 407413084 mucin-associated surface protein (MASP), putative [45, 46]
71407848/ 71664661 calpain-like cysteine peptidase (CLCP) [46, 47]
Two-tandem discontinuous Optiprep gradient ultracentrifugation was performed to highly purify DRMs. The resulting material was analyzed by LC-MS-MS.
The most representative membrane proteins identified are listed together with their Gene DB accession number. For a complete list of identified proteins
see S1 Table.
doi:10.1371/journal.ppat.1005559.t001
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As a whole, our results support that the TS is shed from the trypomastigote surface included
in microvesicles rather than in a soluble form after endogenous PI-PLC digestion. In addition
to the physiological relevance of this finding, TS becomes a suitable marker for these secreted
vesicles.
Discussion
The glycobiology, and membrane dynamics of T. cruzi trypomastigotes are almost unknown
due to the scarcity of assays on membrane biology of this infective parasite stage. Here we
investigated two of the most relevant surface proteins that interact with the mammalian host
during the infection. Mucins and TS are substrate and enzyme respectively in the sialylation
interplay with a central role in the transference of the sialyl residue from the host. The unnatu-
ral sugars approach allowed us to address multiple experiments with unnoticeable chemical
perturbation and high selectivity to the recently transferred sialic acid.
The kinetics of sialyl residue acquisition and the turnover of the sialylated mucins together
with their surface distribution were addressed. A striking finding was that TS and its mucin
substrate do not colocalize at the parasite surface. Trypomastigotes glycoconjugates distribu-
tion had been previously addressed by ruthenium red staining [8], a dye used for electron
Fig 6. Atomic force microscopy (AFM). Trypomastigotes were AFM imaged by tapping mode. Upper panels show height traces and bottom panels show
3D transformation. Special focus was done over the flagellum where heterogeneous and irregular domains following parallel structures along the flagellum
could be observed. Arrows indicate neighboring domains to highlight size distribution and domain separation. Flag: flagellum.
doi:10.1371/journal.ppat.1005559.g006
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microscopy detection of saccharides. Authors found a dense coat of labeling that was inter-
preted as a uniform distribution of mucins. However here we found that mucins, either sialy-
lated or α-Galactosylated, were actually distributed in patches instead (Figs 1 and 2).
The linear repetitive SAPA extension of the TS acts as a spacer that separates its catalytic
domain from the membrane [28, 51]. Depending on the T. cruzi strain, TS isoforms may be
expressed with even more than twenty repetitive units (of a motif of twelve aminoacid residues
each). A SAPA extension of twelve repetitive units will avert the TS catalytic domain to about
50nm away from the cell surface. The combination of confocal and superresolution microsco-
pies used here determined that domains for mucins and TS should be separated apart by about
150nm. Due to this spatial distribution, membrane anchored TS becomes unable to sialylate
mucins. Independent biochemical evidence is presented to support the segregation of these two
kinds of molecules on the trypomastigote surface. These proteins have shown via detergent sus-
ceptibility to be anchored to microdomains with different lipidic environments. Thus, we spec-
ulated on alternatives of how mucins might become sialylated by TS: (i) newly synthesized
mucins could go through a TS-rich area when passing through the flagellar pocket to the sur-
face thus becoming immediately sialylated or (ii) mucins become sialylated by the TS shed to
the extracellular environment. To study the first hypothesis, we followed the sialylation of
newly synthesized mucins. These were neither found colocalizing with TS nor associated to a
specific region of the parasite (see S3A Fig). These results support that newly exposed mucins
haven’t been in close contact with TS all along their path to the surface. To obtain direct evi-
dence of the ability of the shed TS to label the surface of distant parasites, we incubated PFA-
fixed trypomastigotes with live parasites. Fast acquisition (1 min) of sialyl residues was
observed, consistent with the involvement of the shed TS in this process (S3B Fig). The hypoth-
esis associating the shed TS with mucins sialylation is also supported by the fact that TS is rap-
idly detected in trypomastigote-conditioned supernatants [6] as well as in the cytoplasm of
infected cells loaded with trypomastigotes [54]. Thus, in vivo when infected cells burst, high
amounts of TS and trypomastigotes become in contact with sialic acid donors from the extra-
cellular milieu, leading to a rapid sugar acquisition by the parasites. The combination of nano-
scale microscopic techniques such as AFM displaying membrane topology and GSDIM dis-
playing specific protein distribution have shown how the membrane of T. cruzi is covered in
microdomains which are 10nm to 90nm wide and packed close together. We have also shown
by confocal microscopy how these membrane domains are forming a protein-specific patch-
work, particularly concentrated in the flagellum. Therefore, not only are microdomains for
mucins and TS separated apart but also between them there exists a dense patchwork of pro-
tein-packed microdomains, which presents an additional steric hindrance for the bound TS to
access mucins. Analyzing the big picture, the hypothesis that membrane bound TS is unavail-
able to sialylate mucins finds further support.
The finding that two different mucin types based in their glycosylation pattern do exist in T.
cruzi was also astonishing. From the initial studies it was observed that mucins are the main
Fig 7. trans-Sialidase is shed in microvesicles.Western blots of microvesicles purified by two
independent methods, Exoquick kit (A) and ultracentrifugation (B), show TS presence only in the
microvesicles fraction. Mucins were found predominantly in microvesicles although also to a minor extent in
the supernatant. TolT and CLCP proteins contained in DRMs, were not found in the conditioned media (A).
TS was hydrolyzed by the addition of recombinant PI-PLC (rPI-PLC) frommicrovesicles (C) and from
trypomastigotes (D) confirming the absence of endogenous PI-PLC. TS was also found in microvesicles from
the supernatant of infected cell cultures evidencing no involvement of PI-PLC activity from Vero cells or
amastigotes (E). F) and G) are TEMmicrographs of microvesicles purified by Exoquick and
ultracentrifugation respectively. Try; trypomastigotes, CM; conditioned medium, μV; microvesicles; SN;
supernatant.
doi:10.1371/journal.ppat.1005559.g007
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acceptors of sialyl residues [10]. In search of the proteins containing the biologically relevant
αGal epitope, the lab from Dr. Almeida biochemically characterized them as mucins [20].
Organic solvents extraction rendered heavily O-glycosylated proteins containing αGal and sia-
lyl residues [20]. We followed this purification protocol and parallel pull-down assays to dem-
onstrate that the Neu5Az-sialylated proteins were actually tGPI-mucins (Fig 1). Particularly,
sialylation and αGalactosylation are both possible modifications on terminal ßGal-bearing gly-
cans and copurify by mucin extraction procedures. Interestingly, αGalactosylation occurs
intracellularly whereas sialylation is an extracellular modification. Hence, a major question
regarding mucin identity is whether the same mucin molecule can be both terminally deco-
rated with αGal and sialyl residues. We present evidence of only partial co-occurrence of these
residues in membrane domains. Our results indicate that sialyl and αGal residues could be in
some cases linked to the same glycoconjugate and in other cases contained in different mucin
populations. Whether they are representatives of different gene families or just different glyco-
sylation of similar proteins are motive of future research. These unexpected findings add
another degree of complexity to the parasite surface composition/structure. It is noteworthy
that sialylation of parasites prevents their damage by anti-αGal antibodies present in chagasic
patients [8]. However, the access of antibodies directed to αGal in sialylated parasites indicates
that sialylation does not mask those epitopes.
The TS from T. cruzi is found in blood of acutely infected mammals. However, the exact
way through which it is shed remained elusive. Due to its GPI-anchor, TS shedding through
endogenous PI-PLC hydrolysis was proposed [28, 37, 51]. However, PI-PLC expression is
developmentally regulated along the life cycle of T. cruzi and it is only expressed during the dif-
ferentiation of trypomastigotes to amastigotes and just before the re-differentiation to trypo-
mastigotes [53, 55] while in trypomastigotes it could not be detected [52]. In amastigotes,
PI-PLC is exported to the plasma membrane by a process driven by two lipid anchors [56, 57].
The addition of an exogenous PI-PLC probed that the TS-anchor is already available to these
enzymes (Fig 7). However, we found that TS was only shed in microvesicles instead. No TS
remained in the supernatants after microvesicles depletion confirming that PI-PLC is not
expressed in trypomastigotes as previously reported [52]. Pioneering works on TS reported
that, by molecular exclusion chromatography, TS was found in fractions sized over 700kD.
This finding was interpreted as protein oligomerization through the SAPA repeats based on
the idea that the GPI anchor was hydrolyzed by an endogenous PI-PLC [28, 51]. It has also
been reported that TS is shed in vesicles ranging 20-80nm consistent with the vesicle size
described here [58]. In view of the results shown here, the observed molecular mass of the
secreted TS could therefore be explained due to its association to vesicles. Thus the classical
paradigm of TS shedding through hydrolysis of its GPI-anchor should be revisited.
Trypomastigote surface seems to be rugous due to the presence of proteins [24, 59]. How-
ever, it constituted an overwhelming finding to realize that different classes of proteins are
almost individually located in separate islets at the parasite surface. Different proteins tested
were found located to different domains following a patchwork display. Some of them were
clearly associated with the flagellum such as CCLP, TolT or KMP while others were more
evenly distributed such as mucins, TS or ADK-1. It is interesting to compare results from T.
cruzi with those from T. brucei. The flagellum of T. brucei is highly enriched with lipid rafts
[35] that are smaller in size and not resolvable by light microscopy unless the membrane fluid-
ity is tightened with dimethyl sulfoxide addition, a trick that was not necessary with T. cruzi. In
this sense we have to recall that T. cruzimembranes contain mainly ergosterol instead of cho-
lesterol, which is known to favor the production of highly stable DRMs in yeast [60]. It is inter-
esting to observe a similar phenomenon when comparing lipid rafts in the flagellum and cell
body of T. cruzi trypomastigotes. Whereas domains in the cell body (i.e. mucins, TS, ADK-1)
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are discrete, domains for flagellar proteins (i.e. CLCP, TolT, KMP) are smaller and barely
resolvable, showing the same trend as for flagellar lipid rafts in T. brucei. From the results
reported here it seems that, in T. cruzi, lipid rafts constitute an organizing principle by which
proteins are specifically segregated on special areas of the surface as demonstrated in mamma-
lian cells. Moreover, lipid rafts are not the only lipidic structure present in the trypomastigote
membrane since other relevant proteins such as TS are included in detergent sensitive
domains. We support the idea that each domain, regarding the specific proteins and lipids it
bears, will present differential physicochemical properties [61] and will contribute to the
orchestrated and variable membrane physiology of trypomastigotes along the biology of this T.
cruzi stage. However, it still remains unknown how static or dynamic these domains are and
their association with the cytoskeleton [62]. We hypothesize that some of these domains may
serve as scaffolds for the formation of curved membranes that result in the budding of vesicles
[63–66] while others or the same domains may also be important for the adhesion and invasion
processes. It is important to establish the idea of an ordered and compartmentalized membrane
in trypomastigotes and to establish which physiological events are associated to this ordered
nature (see Fig 8 for a model). Through the integrated study of their glycobiology, T. cruzi try-
pomastigotes begin to unveil their membrane physiology.
Materials and Methods
Ethics statement
The protocol of animal immunization followed in this study was approved by the Committee
on the Ethics of Animal Experiments of the Universidad Nacional de San Martín, according
with the recommendations of the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health
Parasites
Tissue culture-derived trypomastigotes of the CL-Brener strain of T. cruzi were obtained from
supernatant of infected Vero cells (ATCC, VA) cultured in Minimum Essential Medium
(MEM) (Gibco, NY) plus 4% fetal bovine serum (FBS, Gibco) at 37°C and 5% CO2. Epimasti-
gotes of the same parasite strain were axenically grown in LIT (Liver infusion-Tryptose)
medium (Gibco).
Staudinger-Bertozzi click chemistry for sialic acid labeling of acceptor
molecules
To specifically label recently transferred sialic acid we used the Staudinger-Bertozzi (copper
free) click-chemistry approach [22, 23]. Neu5Az-LacβOMe (Neu5AzLac) and Neu5Az-Gal-
βOMe (Neu5AzGal) were synthesized [67]. The Neu5Az sialic acid was reacted with several
compounds: Phos-FLAG, Phos-(PEG)3-Biotin (Thermo Scientific, Waltham, MA) DBCO-
(PEG)4-Biotin and DBCO-FLAG (Jena Bioscience, Germany) [30, 31]. All compounds were
used at saturating conditions. Equivalent labeling between compounds was verified by Western
blot and immunofluorescence. Phos-FLAG or DBCO-FLAG were preferred for imaging
because they showed significant lower background. To label the parasites with Neu5Az, they
were incubated for 30min in PBS containing 1mMNeu5AzLac or Neu5AzGal as donor and
10mM 2-deoxi-Glucose (Sigma, MO). The enzymatic labeling was done by the endogenous
parasite-derived TS in the case of trypomastigotes or by the addition of recombinant TS (10ng/
106 cells) for epimastigotes. After thoroughly washing, parasites were incubated overnight with
Phosphine compounds or for 30min with DBCO compounds, which have faster reaction
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Fig 8. Themembrane of trypomastigotes is complex to the nanometer scale.Membrane model for T. cruzi trypomastigotes. The surface is packed in
microdomains of different size, shape, lipid composition and embedded proteins. Some of these domains are detergent resistant, however this does not
imply a functional profile. Mucins are included in DRMs whereas TS is not, thus being segregated in the membrane of trypomastigotes. This challenges the
membrane bound TS as the sialylating factor for mucins, a role proposed for the shed TS instead. DRMs embed different proteins, many of them localized to
the flagellum. Flagellum domains tend to be smaller and closer together than those in the cell body and suggest an association to the flagellar cytoskeleton.
Mucins and TS are shed to the extracellular environment included in microvesicles probably resulting frommembrane budding and fission events.
Furthermore, TS is shed associated to vesicles instead of as a soluble protein. No hydrolysis of the GPI-anchors occurs in the trypomastigote stage.
doi:10.1371/journal.ppat.1005559.g008
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kinetics [30, 31]. As controls, trypomastigotes were incubated with 3’sialyllactose (Carbosynth,
UK) and labeled through the same procedure.
Recombinant protein expression and purification
Recombinant TS was expressed in bacteria and purified as described elsewhere [3]. CLCP [47],
KMP-11 [41, 42] and Tol-T [40] encoding genes were cloned by PCR performed on genomic
T. cruzi DNA and cloned into pTrcHis (Invitrogen) to be expressed in Escherichia coli BL21.
Proteins were purified by immobilized metal affinity chromatography through Ni2+-charged
Hi-Trap chelating columns (GE-Healthcare) to immunize BALB/cJ mice. The central and vari-
able region (nucleotides 109 to 390) of one TcMUCII gene (GenBank U32448.1) was cloned by
PCR into pGEX-1λT vector (GE Healthcare). GST-TcMUCII protein was expressed and puri-
fied by affinity chromatography and used for immunization. The protocol of animal immuni-
zation followed in this study was approved by the Committee on the Ethics of Animal
Experiments of the Universidad Nacional de San Martín (UNSAM), according with the recom-
mendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes
of Health.
Mucin purification
Heavily O-glycosylated mucins were extracted from Neu5Az-trans-sialylated trypomastigotes
with organic solvents as described in [20] and then the sialylation checked in extracted material
by Western blots. Briefly, 900x106 parasites were extracted with Chloroform/Methanol/water
(5:10:4), centrifuged at 12,000Xg and pellet and extract dried under N2. The extract was treated
with butanol/water (2:1) and centrifuged at 12,000Xg to separate butanolic (F1) and aqueous
phase (F2). The pellet was extracted with 9% butanol and the 12,000Xg supernatant (F3) sepa-
rated from the cell debris.
Pull-down of sialylated proteins
Trypomastigotes (900×106) were pulsed with Neu5Az donors as above, rinsed and coupled for
30min with DBCO-FLAG. Then parasites were resuspended in 300μl of IP buffer (150mM
NaCl; 0,1%, Np40; 1% Triton X100; 50mM Tris-HCl pH7.6; Sigma protease inhibitor cocktail
plus 50μMTosyl-L-lysine Chloromethyl ketone hydrochloride (TLCK)) and lysed for 20min at
RT followed by 40min on ice with occasional homogenization. The lysate was clarified by two
centrifugation steps (15min; 10,000rpm; 4°C) and pellets discarded. An anti-FLAG (M2 clone)
antibody coupled to a resin (Sigma) (25μl) was rinsed 4X with 500μl of IP buffer. One third of
the clarified lysate was kept as the Input fraction and the other were pulled down with anti-
FLAG antibodies, the supernatant was kept as the Unbound fraction. Resin was washed,
cracked and processed for Western blots revealed with mouse antibodies anti-TcMUCII.
Immunofluorescence microscopy
For immunofluorescence microscopy, 12mm coverslips (Marienfeld, Germany) were coated
with 0.2mg/ml poly-L-lysine (Sigma), rinsed and air-dried. Trypomastigotes were fixed for 1h
at 4°C with 4% EM grade PFA, (Electron Microscopy Sciences, PA) and settled for 1h on
coated coverslips. Samples were blocked with 0.45μm-filtered 2% biotechnology grade-bovine
serum albumin (BSA, Amresco, OH) in PBS. Either primary mAb or immune sera were diluted
in blocking solutions. AlexaFluor488 and AlexaFluor568 coupled secondary antibodies (Invi-
trogen, IL) were used at a final concentration of 2μg/ml. Coverslips were mounted using Fluor-
Save (Calbiochem, Germany). Epi-fluorescence imaging was done under a Nikon Eclipse E600
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microscope equipped with a 100× NA:1.4 objective and with a Diagnostic Instruments SPOT
RT Slider CCD camera. Exposure times were shorter than those in which no signal was
recorded for negative control. Confocal imaging was done under an Olympus FV1000 micro-
scope equipped with a 100× NA:1.4 or 60× NA:1.44 objective. Pinhole was set to obtain mini-
mum-thick Z slices (0.8μm). Resolution was set to generously cover Rayleigh criterion.
Maximum photo-multiplier HV parameter was determined with negative controls. The dis-
played images correspond to a single slice of the confocal stack. All images were taken at room
temperature. Advanced microscopy techniques are described separately. Images and colocali-
zation profiles were analyzed using ImageJ (NIH, Bethesda).
GSDIM superresolution microscopy
Image acquisition. Single molecule images were acquired on a home-built wide field
microscope with EMCCD (IXON-DU-897; Andor Technology) detection. The samples were
continuously excited with 532nm laser diode (SDL-532-200T; Shanghai Dream Lasers Tech-
nology) and power density was controlled with a neutral density filter between 1kW/cm2 to
30kW/cm2. In order to achieve an optimal event number per frame, a 405nm laser (SDL-
405-LM-20-T; Shanghai Dream Lasers Technology) was used to depopulate the dark states at a
power density of 0.6kW/cm2. This laser was switched on and off using a homemade pulse gen-
eration unit connected to the fire signal of the EMCCD and the blanking signal of the lasers. In
this manner, the sample was irradiated for short periods, preferable between frames. Both laser
beams were collinearly overlapped (DCLP 425 (DCXR) AHF, and focused (Achromat f200
lens) onto the back focal plane of a Leica PLAN 100× objective, 1.25 NA, oil immersion, to
achieve wide-field illumination. Single molecule fluorescence emission was collected by the
same objective, and separated from the excitation beams by means of a dichroic mirror (Z488-
532rpc; Chroma Technology). Emission filters were chosen for Alexa532 (562–40, Semrock
Inc.) and Alexa568 (605–40, Chroma Technology) and placed in front of the detector. Excita-
tion residual light was further cleaned with a notch filter (NF01-532U-25; Semrock Inc.). The
pixel size of 83×83nm2 on the focal plane was calibrated with a resolution test pattern (USAF
1951 RES TARGET 2IN, Edmund Optics). Typically, sequences of images were recorded onto
a 70×70 pixel region of the EMCCD camera (ca. 6×6μm). Image acquisition was performed
with the software of the provider of the camera (Andor Solis; Andor Technology) at an expo-
sure time of 50ms. XY in plane stability of the system was followed in time with fluorescent
bead samples (TetraSpeck Microspheres, 100nm, blue/green/orange/dark red fluorescent, Life
technologies). Typically, random fluctuations were smaller than 5nm. All measurements were
performed at room temperature. Sequences of images were acquired consecutively till the num-
ber of events per frame was too low for SR imaging, thus a typical imaging experiment con-
sisted of ca. 30,000 frames.
Imaging buffers. Imaging buffer contained TN buffer (50mM Tris, pH 8.0, 10mM NaCl),
an oxygen scavenging system (0.5mg/ml glucose oxidase (Sigma), 40μg/ml catalase (Roche
Applied Science; Sigma), and 10% (w/v) glucose (Sigma)), and 10mM 2-mercaptoethanol
(Fluka, Germany). Imaging buffer was optimized for the system as described elsewhere [68].
Image processing software. Localization of single-molecule events and the superresolu-
tion image reconstruction were performed automatically by a series of homemade routines
(written in Matlab Software) applied to the imaged stacks. Briefly, each frame was processed
with a smoothing Gaussian filter and events were identified as a cluster of pixels (typically> 5)
with intensity higher than a threshold, set as at least four times the standard deviation of the
background signal. Then, the center of mass was determined for each cluster. The exact posi-
tion of each cluster was determined with a procedure based on a Gaussian mask-fitting
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algorithm described in detail elsewhere [69, 70]. As an output, a list of localized events was con-
structed. The list contained the position, intensity in number of collected photons (based on a
calibration over the camera detection) [71] and the frame where the event occurred. Events
that appeared in consecutive frames at the same position (within an error of ca. 100nm, i.e.
about one pixel) were considered as the same molecule and added to a single burst (photons
were added and position recalculated). This analysis allowed estimating the mean on time of
the fluorophores, data that was used to set an appropriate imaging frame rate. The final image
was generated by plotting a 2D histogram of the list of positions rendered by the localization
routine. The imaged area was reconstructed with a pixel size of about one half of the theoretical
average final resolution (calculated from the distribution of the number of photons detected
per localized event), and the intensity of each pixel was assigned as the number of single mole-
cules localized within its area.
Atomic force microscopy
Trypomastigotes were rinsed twice in PBS and fixed in 4% p-formaldehyde. Then, 106 trypomas-
tigotes were settled on poly-L-lysine treated coverslips, dehydrated by increasing ethanol concen-
tration series and critical point dried. Images were taken using a Veeco Nanoscope III atomic
force microscope in tapping mode under a N2 atmosphere. MPP-11100 cantilevers (Nanode-
vices, CA) with spring constant of 40N/m; f0 = 300Khz and r<10nmwere used. Images were
processed withWSxM software fromWSxM solutions (www.wsxmsolutions.com).
Mucin shedding kinetics
Trypomastigotes (150×106) were pulsed for 30min with Neu5AzLac as described above, rinsed
and resuspended in RPMI 1640 medium (Gibco). Trypomastigotes were aliquoted and incu-
bated at 37°C in 5% CO2. Every 30min an aliquot was withdrawn, centrifuged and the pellet
separated from the conditioned medium. After 120min, one aliquot was re-pulsed with
Neu5AzLac for 30min. For immunofluorescence assays, parasites were fixed as above, rinsed
and incubated overnight with Phos-FLAG. Fluorescence intensity was quantified by flow
cytometry. For Western blot analysis, parasites were lysed in Lysis buffer (150mM NaCl, 1%
Triton X-100, 50mM Tris-HCl pH 7.6, 1X protease inhibitor cocktail (Sigma), 50μMTLCK
and 13G9 TS-neutralizing mAb) [29], then incubated overnight with Phos-FLAG at 4°C. Con-
ditioned media were supplemented with 1X protease inhibitor cocktail, 50μM TLCK plus 13G9
mAb and then incubated with Phos-FLAG overnight at 4°C. Western blots from pellets and
conditioned media from 10% SDS-PAGE were developed with a rat anti-FLAG mAb (Biole-
gend, CA) using a chemioluminescent substrate (Thermo Scientific, IL).
Differential Neu5Az uptake
Trypomastigotes (150×106) were pulsed for 30min with 3’sialyllactose, rinsed, aliquoted and
reincubated with Neu5AzLac for 30sec to 15min. Then, parasites were fixed immediately in 4%
PFA. All aliquots were rinsed twice and incubated overnight with Phos-FLAG. Immunofluo-
rescence assays were conducted against FLAG and TS.
Sialylation of trypomastigotes by shed TS
Trypomastigotes where labeled with mouse mAb 13G9 at saturating conditions, washed and
fixed with PFA. Fixed trypomastigotes were exhaustively rinsed and resuspended to 160×106
parasites/ml and Neu5AzGal was added to 1mM. Several 25μl-aliquots containing 4×106 para-
sites were prepared. Separately, live trypomastigotes were rinsed and resuspended to 160×106
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parasites/ml and 25μl were added to each aliquot of fixed parasites. At given times, co-incuba-
tion was stopped by addition of an equal volume of 4% PFA. As a negative control, an aliquot
was added with 4% PFA before addition of the live trypomastigotes. As positive control 8×106
fixed parasites were incubated with 250ng of recombinant TS for 30 min. To label Neu5Az resi-
dues, parasites were rinsed and incubated overnight with PhosFLAG. Rat anti-FLAG antibod-
ies and anti-Rat Alexa488 secondary antibodies were used for Neu5Az staining and anti-mouse
Alexa568 secondary antibodies were used to identify mAb 13G9-labeled parasites.
Triton X-100 assay for DRM
Trypomastigotes (100×106) were pulsed for 30min with Neu5AzGal as described above, rinsed
and lysed in 100μl of lysis buffer at 4°C for 30 min. Then, the lysate was centrifuged at 10,000xg
in an SS34 rotor at 4°C. Pellets and supernatants were stored at -20°C overnight. Pellet was resus-
pended in 100μl lysis buffer (added with protease inhibitor cocktail (Sigma) plus 50μMTLCK
and 13G9mAb) and Phos-FLAG. The supernatant was supplemented with protease inhibitor
cocktail (Sigma), 50μMTLCK, 13G9mAb and reacted with Phos-FLAG. Samples were incubated
overnight at 4°C cracked and ran in a 10% SDS-PAGE to performWestern blots.
Triton X-114 assay for GPI-anchored proteins
Trypomastigotes (100×106) were pulsed for 30min with Neu5AzGal as described above, rinsed
and reacted with DBCO-Biotin for 30min. Then parasites were lysed for 1h at 4°C in 2ml Tri-
ton X-114 extraction buffer (150mM NaCl, 2% Triton X-114, 50mM Tris pH 7.6, protease
inhibitor cocktail (Sigma) and 50μMTLCK). Lysate was stored at -20°C overnight. Then, the
lysate was incubated for 10min at 37°C and centrifuged at 3,000g for 10min at room tempera-
ture. Detergent and aqueous phases were collected and precipitated overnight with 3 volumes
of cold acetone at -20°C. Precipitates were cracked to performWestern blots.
Step gradient purification of DRMs
Trypomastigotes (800×106) were pulsed for 30min with Neu5AzGal as above, rinsed and sepa-
rated in half. Each aliquot was lysed in 1ml of lysis buffer supplemented with DBCO-Biotin either
on ice or at 37°C for 45 min. Then, lysates were deposited on the bottom of ultracentrifuge tubes
and adjusted to 40% OptiPrep by adding 2ml of a 60% OptiPrep solution (Sigma). On top of the
40% OptiPrep layer, 5ml of a 35% OptiPrep solution was settled. Finally, the tube was filled with
a layer of 5% OptiPrep. All OptiPrep solutions were fixed to 150mMNaCl, 50mM Tris pH 7.6
and 1% Triton X-100. Samples were then centrifuged in a Beckman Optima XL-100K ultracentri-
fuge using an SW41Ti rotor. Samples were continuously centrifuged at 35,000rpm 210,053×g
(max) for 5h and then at 25,000rpm 107,170×g (max) for 12h at 4°C. Finally, 1ml aliquots were
withdrawn top to bottom except for the two interfaces, which were collected in 300μl to avoid
dilution and contamination. Fifty μl of each aliquot were cracked for Western blot.
Mass spectrometry of DRMs
DRMs were prepared for MS by two consecutive step-gradient purifications as described
above. Trypomastigotes (800×106) were lysed and centrifuged as above. The 35%/5% OptiPrep
interface was collected in 1ml into an ultracentrifuge tube, mixed with 60% OptiPrep to a final
40% OptiPrep concentration and purification continued as before. After the second centrifuga-
tion step, the 35%-5% OptiPrep interface was collected in 300μl to avoid contamination and
precipitated with 3 volumes of cold acetone. Samples were analyzed at ITSI-Biosciences (Johns-
town, PA) by in solution digestion and tandem mass spectrometry analysis using nano-LC/
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MS/MS. After digestion, peptides were dried and reconstituted in 2% Acetonitrile with 0.1%
Formic acid. After salt removing, samples were loaded onto a PicoFrit C18 nanospray column
(New Objective) using a Thermo Scientific Surveyor Autosampler operated in the no waste
injection mode. Peptides were eluted with a 2–32% linear Acetonitrile gradient over 230 min-
utes followed by high and low organic washes for another 5 min into an LTQ XL mass spec-
trometer (Thermo Scientific) via a nanospray source with the spray voltage set to 1.8kV and
the ion transfer capillary set at 180°C. A full MS scan from m/z 350–1500 was followed by MS/
MS scans on the seven most abundant ions. Raw data files were searched using Proteome Dis-
coverer 1.3 (Thermo Scientific) and the SEQUEST algorithm against the most recent species-
specific database for T. cruzi from NCBI. Trypsin was the selected enzyme allowing for up to
two missed cleavages per peptide, Carbamidomethyl Cysteine was used as a static modification
and Oxidation of Methionine as a variable modification. Proteins were identified when two or
more unique peptides had X-correlation scores greater than 1.5, 2.0, and 2.5 for respective
charge states of +1, +2, and +3. A total of 152 proteins were identified.
Membrane fluidity assay
Trypomastigotes were pulsed for 30min with Neu5AzLac as above, rinsed and settled over
poly-L-lysine (Sigma)-treated coverslips for 10min. Then, the coverslips were inverted on
freshly prepared solutions of PBS or PBS plus 1% diethyl ether. Coverslips were incubated for
30, 60 or 90sec and immediately inverted over 4% PFA. Coverslips were then processed for
immunofluorescence as above.
Microvesicle harvest of trypomastigote conditioned media
Trypomastigotes (200×106) were pulsed for 30min with Neu5AzLac, rinsed and incubated in
200μl of FBS-free RPMI-1640 plus DBCO-Biotin for 90min at 37°C and 5% CO2. Parasites were
separated by four consecutive centrifugation rounds, two at 2700×g for 10min followed by two
centrifugations at 10,600×g for 10min. The cell-free conditioned medium was supplemented
with 10% FBS to a final volume of 100μl. Exosome purification kit (System Biosciences, CA) was
added to the conditioned medium and microvesicles were purified according to the manufactur-
ers protocol. Briefly, the Exoquick supplemented conditioned medium was allowed to settle at 1g
overnight and then centrifuged 30min at 1,500xg. The pellet containing microvesicles was
cracked in a final volume of 100μl while proteins in the supernatant were precipitated with 3 vol-
umes of cold acetone, stored at -20°C overnight and centrifuged at 13,000g for 30min. Precipi-
tated proteins were cracked in a final volume of 100μl and developed byWestern blot.
Microvesicle harvest by ultracentrifugation
Trypomastigotes (240×106) were rinsed and incubated in 10ml of FBS-free RPMI-1640 for
90min at 37°C and 5% CO2. Trypomastigotes were separated by four consecutive centrifuga-
tion rounds as before. The cell-free conditioned medium was centrifuged in a Beckman Optima
XL-100K ultracentrifuge using a Type 70 Ti rotor at 31,000 rpm 98,914 xg (max) for 90min.
Pellet was resuspended in 500μl of TBS and the supernatants were precipitated with cold ace-
tone overnight at 4°C and resuspended in 500μl of TBS. All aliquots were cracked and devel-
oped by Western blots.
Transmission Electron Microscopy (TEM)
Microvesicles harvested either by Exoquick (FBS-free) or ultracentrifugation were fixed with
4% EM-grade PFA in TEM-buffer (50mM HEPES, pH6.5) and 10μl of the suspension were
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absorbed in GO coated copper grids (200 mesh). Samples were pos-fixed in 1% EM-grade glu-
taraldehyde in TEM-buffer and rinsed with deionized water, then stained with 2% Uranyl ace-
tate for 1min and dried at room temperature. Micrographs were acquired in a Carl Zeiss EM
109T transmission electron microscope operating at 80kV and equipped with a Gatan
ES1000W (11 Mpixel) digital camera.
PI-PLC treatment on trypomastigote microvesicles and conditioned
medium
Trypomastigotes (200×106) were rinsed and resuspended in 350μl of FBS-free RPMI-1640.
Parasites were incubated for 2h at 37°C, 5% CO2 and then separated from the conditioned
medium by consecutive centrifugation steps as above. The resulting conditioned medium
(300μl) was split in half; one to serve as control and the other was supplemented with 0.5 enzy-
matic units of PI-PLC (Invitrogen) and incubated 30min at 37°C, 5% CO2. Then, both samples
were supplemented with 10% FBS and microvesicles harvested using the Exoquick kit as above.
Pellets and proteins precipitated from supernatant by cold acetone were cracked in a final vol-
ume of 100μl and cracked to a final volume of 100μl. Western blots were performed.
PI-PLC treatment during trypomastigote shedding
Rinsed trypomastigotes (200×106) were resuspended in 400μl of serum free RPMI-1640 and
divided into four aliquots (each containing 50×106 parasites in 200μl). Two aliquots served as
controls. The other two were treated for 30 or 90min (PLC30 and PLC90) with 0.5 units of
PI-PLC at 37°C in 5% CO2. At the indicated time, supernatant was depleted of cells and debris
by centrifugation as above. Then, conditioned media were supplemented with 10% FBS and
microvesicles were harvested using Exoquick as before. Pellets were cracked in a final volume
of 100μl while supernatant proteins were precipitated with cold acetone and then cracked to a
final volume of 100μl. Western blots were performed.
Microvesicles harvest on extracellular medium from infected Vero cell
cultures
Supernantants (5 ml) of Vero cell cultures in MEM supplemented with 4% FBS containing
10×106 trypomastigotes/ml were taken at day 7-post-infection. Cells and debris were removed
by centrifugation and microvesicles harvested from 500μl of the cell-free conditioned medium
using the Exoquick kit as above. Pellets were cracked in a final volume of 100μl and superna-
tant proteins were precipitated with cold acetone and later cracked to a final volume of 100μl.
Western blots were performed.
Supporting Information
S1 Fig. Methyl-β-cyclodextrin severely perturbs trypomastigote’s morphology. Trypomasti-
gotes were incubated with methyl-β-cyclodextrin (MβCD) for 30min at different concentra-
tions. (A) Phase contrast images for MβCD treatment at 0-30mM show howMβCD induces
strong alterations to the trypomastigote structure. (B) Western blots for treatments with
MβCD in concentrations between 0-5mM show that mucins are extracted from the trypomas-
tigotes, in line with the microscopic observations. (C) Fluorescence microscopy of trypomasti-
gotes treated with MβCD. Sialic acid is labeled in green and TS in red. Correlative with the
increase in MβCD concentration, trypomastigotes disrupt their size, shape and dotted labeling
of sialic acid (5mM) and TS (10mM). Even though MβCD disrupts lipid rafts, its effect on the
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trypomastigotes was not acceptable for continuing with further analysis. Bar: 5μm.
(TIF)
S2 Fig. Sialic acid acceptors distribution in T. cruzi epimastigotes and metacyclic trypomas-
tigotes. (A) Epimastigotes (upper panel) were sialylated by addition of recombinant TS and
Neu5Az donors. Metacyclic trypomastigotes (lower panel) were incubated with Neu5Az
donors. Parasites were analyzed by confocal microscopy. A dotted pattern can be observed in
both parasite stages. (B) Epimastigotes sialylated as in (A) were assayed for DRM purification.
Sialic acid was incorporated to diffuse bands from 30-60kDa corresponding to the expected
size of the stage-specific mucins. Epimastigotes mucins were also contained in DRMs.
(TIF)
S3 Fig. Mucins do not pass through a TS rich area in the membrane. A) Mucins from trypo-
mastigotes were saturated with sialyl-lactose, exposed to Neu5Az donors for short periods (30sec
to 15min) to label newly exposed sialyl acceptor sites and fixed immediately in 4% p-formalde-
hyde (PFA). Fluorescence images show that in none of the contexts did TS and mucins coloca-
lized, indicating that mucins do not pass through a TS rich area for sialylation. Raw images are
shown to avoid biased observations. B) PFA-Fixed trypomastigotes accept Neu5Az transferred by
the TS shed from neighboring live trypomastigotes. Acceptor trypomastigotes were labeled with
anti-TS 13G9mAb and fixed. Then, fixed parasites were mixed 1:1 with live trypomastigotes in
the presence of Neu5AzGal. At given times aliquots were fixed with PFA, processed with Phos-
FLAG and revealed by immunofluorescence. Acceptor parasites were identified by TS staining
(red fluorescence) and acquired sialyl residue by green fluorescence. Confocal images. Bar: 5μm.
(TIF)
S1 Table. LC-MS-MS of DRM proteins.
(XLSX)
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